2009
DOI: 10.1186/cc7710
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis

Abstract: Introduction Septic encephalopathy secondary to a breakdown of the blood-brain barrier (BBB) is a known complication of sepsis. However, its pathophysiology remains unclear. The present study investigated the effect of complement C5a blockade in preventing BBB damage and pituitary dysfunction during experimental sepsis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
71
0
3

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 91 publications
(79 citation statements)
references
References 79 publications
(60 reference statements)
5
71
0
3
Order By: Relevance
“…Compromised barrier integrity was evidenced in animal model and human sepsis by monitoring the levels or transport of various markers in the brain parenchyma (Jeppsson et al, 1981;Siami et al, 2008). Various cytokines released by activated leukocytes were shown to induce increased pinocytosis by endothelial cells (Anda et al, 1997;Huynh and Dorovini-Zis, 1993) and recently a central role of complement components (C5a) in blood-brain barrier dysfunction in sepsis was shown (Flierl et al, 2009). Apparent diffusion coefficients measured in the cortex and thalamus of septic animals indicated alterations in this parameter, which were related to the outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Compromised barrier integrity was evidenced in animal model and human sepsis by monitoring the levels or transport of various markers in the brain parenchyma (Jeppsson et al, 1981;Siami et al, 2008). Various cytokines released by activated leukocytes were shown to induce increased pinocytosis by endothelial cells (Anda et al, 1997;Huynh and Dorovini-Zis, 1993) and recently a central role of complement components (C5a) in blood-brain barrier dysfunction in sepsis was shown (Flierl et al, 2009). Apparent diffusion coefficients measured in the cortex and thalamus of septic animals indicated alterations in this parameter, which were related to the outcome.…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, some agents with anti-inflammatory action were useful to reduce LPS-induced microglial/astrocyte activation, production of pro-inflammatory mediators and facilitating recovery from neurobehavioural symptoms [11,56,84,118]. Likewise, in models of experimental sepsis there is evidence that blockage of C5a, a small peptide derived from complement activation, can prevent BBB breakdown [45]. It remains to be determined how these findings can be applied to humans.…”
Section: Perspectives On Prevention and Treatment Of Deliriummentioning
confidence: 99%
“…Lipophilic antibiotics (e.g., fluoroquinolones, macrolides, tigecycline, and lincosamides) have lesser alterations in the volume of distribution but can also develop reduced drug clearances, causing an increase of the AUC in plasma (207). In experimental animals sepsis increased cerebral albumin extravasation as an indicator of the impaired integrity of the blood-brain/ blood-CSF barrier (69,92). Therefore, in the majority of cases, sepsis should lead to a moderate increase in the concentrations of anti-infectives in the CSF and other intracranial compartments.…”
Section: Penetration Of Anti-infectives Into the Csf And Brain Tissuementioning
confidence: 99%